Plain-English translation of NCT07504146 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observation study that follows patients who have gout or calcium pyrophosphate deposition disease (a condition where crystals build up in joints). Researchers will track how these crystal deposits develop over time, what happens to them with standard treatments, and whether they cause problems with heart health. The study will compare your experience to patients with osteoarthritis to better understand how these crystal diseases progress.
Doctors know that gout and calcium pyrophosphate deposition disease involve crystals forming in joints, but they don't fully understand how this happens, how fast it progresses, or whether it can damage the heart. This study aims to answer those questions so patients can get better care in the future.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital rheumatology or orthopedic clinic for routine check-ups every 6 months, plus any urgent visits if needed, for up to 10 years. At each visit, you'll have standard physical exams, blood tests, and imaging scans (ultrasound or X-rays) — the same tests you'd normally receive for your condition. Your medical records and test results will be recorded in a study database to help researchers understand how your condition changes over time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy
Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Enrollment target
~450 participants
Started
October 2024
Primary completion
October 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Georgios Filippou, MD
Università degli Studi di Milano / IRCCS Ospedale Galeazzi-Sant'Ambrogio
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.